Pharmacodynamics
Pharmacodynamics — The study of the biochemical and physiological effects of a compound on a biological system, describing what the compound does to the body.
What Is Pharmacodynamics?
Pharmacodynamics (PD) is the study of how a compound affects a biological system, summarized as "what the drug does to the body." While pharmacokinetics describes compound movement and elimination, PD describes the relationship between compound concentration and biological effect. Together, PK/PD modeling predicts optimal dosing for peptide research protocols.
Key PD Parameters
- EC50: Concentration producing 50% of maximal effect (potency measure)
- Emax: Maximum achievable effect (efficacy measure)
- Hill coefficient (n): Steepness of the dose-response curve, indicating cooperativity
- IC50: Concentration producing 50% inhibition (for antagonists and enzyme inhibitors)
- Therapeutic index: Ratio of toxic dose to effective dose, indicating the safety margin
Dose-Response Relationships
The standard dose-response curve is sigmoidal when plotted on a log-concentration scale. Peptide researchers generate these curves by testing 6-8 concentrations spanning 3-4 log units, fitting data to the Hill equation. Shift of the curve indicates changes in potency; change in maximum indicates changes in efficacy. These curves are fundamental to characterizing any bioactive peptide.
Frequently Asked Questions
What is Pharmacodynamics?
The study of the biochemical and physiological effects of a compound on a biological system, describing what the compound does to the body.
Why is Pharmacodynamics important in peptide research?
Pharmacodynamics is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.
Authority Sources
- Pharmacodynamics on Wikipedia
- Search Pharmacodynamics on PubChem (NIH)
- Research articles on ScienceDirect